Atea Pharmaceuticals Inc (AVIR) — Defensive Interval Ratio
Atea Pharmaceuticals Inc (AVIR) has a Defensive Interval Ratio of 1855 days as of June 2026. Defensive assets of $142.92 Million (cash $-, short-term investments $142.92 Million, receivables $-) cover 1855 days of daily cash needs of $77.05K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Atea Pharmaceuticals Inc Defensive Interval Ratio (2020–2025)
This chart shows how Atea Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of June 2026, the ratio stands at 1855 days, meaning defensive assets of $142.92 Million can fund 1855 days of operations without new revenue. For the complete balance sheet picture, see balance sheet size of Atea Pharmaceuticals Inc.
Annual Defensive Interval Ratio for Atea Pharmaceuticals Inc (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Atea Pharmaceuticals Inc from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Atea Pharmaceuticals Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1891 days | $206.12 Million | $109.00K/day | $- | $206.12 Million | ▼ -5761 days |
| 2024 | 7652 days | $390.02 Million | $50.97K/day | $- | $390.02 Million | ▲ +2756 days |
| 2023 | 4896 days | $434.28 Million | $88.70K/day | $- | $434.28 Million | ▼ -4156 days |
| 2022 | 9052 days | $458.25 Million | $50.62K/day | $- | $458.25 Million | ▲ +9052 days |
| 2021 | 0 days | $0.00 | $155.84K/day | $- | $0.00 | ▼ -7 days |
| 2020 | 7 days | $5.82 Million | $865.19K/day | $- | $- | — |